TY  - JOUR
AU  - Lim, Louise
AU  - Powles, Tom
PY  - 2012
TI  - New prognostic models in metastatic renal cancer
JF  - Translational Andrology and Urology; Vol 1, No 3 (September 17, 2012): Translational Andrology and Urology
Y2  - 2012
KW  - 
N2  - Currently 7 targeted therapies have been approved for the treatment of advanced RCC: sorafenib, sunitinib, temsirolimus, axitinib, bevacizumab in combination with interferon-α, everolimus and pazopanib (1). There is difficulty distinguishing between them due to lack of head to head studies. Therefore there are multiple treatment options for patients in the first and second line setting.
UR  - https://tau.amegroups.org/article/view/1061